378 related articles for article (PubMed ID: 19341433)
21. HMB-45 expression in a clear cell variant of atypical fibroxanthoma.
Cai JP; Randall B
J Cutan Pathol; 2006 Feb; 33(2):186-8. PubMed ID: 16420318
[No Abstract] [Full Text] [Related]
22. Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma.
Ly H; Selva D; James CL; Huilgol SC
Australas J Dermatol; 2004 May; 45(2):106-9. PubMed ID: 15068457
[TBL] [Abstract][Full Text] [Related]
23. More than 2 decades of treating atypical fibroxanthoma at mayo clinic: what have we learned from 91 patients?
Ang GC; Roenigk RK; Otley CC; Kim Phillips P; Weaver AL
Dermatol Surg; 2009 May; 35(5):765-72. PubMed ID: 19389106
[TBL] [Abstract][Full Text] [Related]
24. Aspects of the differential diagnosis of clear-cell lesions of the skin in connection with the rare case of a clear-cell atypical fibroxanthoma.
Kemmerling R; Dietze O; Müller S; Neureiter D
Pathol Res Pract; 2009; 205(5):365-70. PubMed ID: 19155147
[TBL] [Abstract][Full Text] [Related]
25. CD117 immunoreactivity in atypical fibroxanthoma.
Mathew RA; Schlauder SM; Calder KB; Morgan MB
Am J Dermatopathol; 2008 Feb; 30(1):34-6. PubMed ID: 18212542
[TBL] [Abstract][Full Text] [Related]
26. Atypical fibroxanthoma: a clinicopathological study of 89 cases.
Mirza B; Weedon D
Australas J Dermatol; 2005 Nov; 46(4):235-8. PubMed ID: 16197421
[TBL] [Abstract][Full Text] [Related]
27. Atypical Fibroxanthoma: A case series and review of literature.
Mahalingam S; Shah A; Stewart A
Auris Nasus Larynx; 2015 Dec; 42(6):469-71. PubMed ID: 25912604
[TBL] [Abstract][Full Text] [Related]
28. An unusual presentation of atypical fibroxanthoma.
Vandergriff TW; Reed JA; Orengo IF
Dermatol Online J; 2008 Jan; 14(1):6. PubMed ID: 18319023
[TBL] [Abstract][Full Text] [Related]
29. Atypical fibroxanthoma: Case series of 16 patients.
Wylie J; Hampton N; Telfer MR; Clarke AM
Br J Oral Maxillofac Surg; 2010 Sep; 48(6):466-8. PubMed ID: 20129724
[TBL] [Abstract][Full Text] [Related]
30. Atypical fibroxanthoma--a retrospective immunohistochemical study of 42 cases.
Singh M; Mann R; Ilankovan V; Hussein K; D'arrigo C
J Oral Maxillofac Surg; 2012 Nov; 70(11):2713-8. PubMed ID: 22494510
[TBL] [Abstract][Full Text] [Related]
31. INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics.
Orrock JM; Abbott JJ; Gibson LE; Folpe AL
Am J Dermatopathol; 2009 Apr; 31(2):152-6. PubMed ID: 19318800
[TBL] [Abstract][Full Text] [Related]
32. Subcutaneous atypical fibrous histiocytoma.
Garrido-Ruiz MC; Ramos P; Enguita AB; Rodriguez Peralto JL
Am J Dermatopathol; 2009 Jul; 31(5):499-501. PubMed ID: 19542931
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous balloon cell dermatofibroma (fibrous histiocytoma).
Tran TA; Hayner-Buchan A; Jones DM; McRorie D; Carlson JA
Am J Dermatopathol; 2007 Apr; 29(2):197-200. PubMed ID: 17414448
[TBL] [Abstract][Full Text] [Related]
34. Primitive nonneural granular cell tumor (so-called atypical polypoid granular cell tumor). Report of 2 cases with immunohistochemical and ultrastructural correlation.
Habeeb AA; Salama S
Am J Dermatopathol; 2008 Apr; 30(2):156-9. PubMed ID: 18360120
[TBL] [Abstract][Full Text] [Related]
35. High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.
Hanly AJ; Jordà M; Elgart GW; Badiavas E; Nassiri M; Nadji M
Arch Pathol Lab Med; 2006 Jun; 130(6):831-4. PubMed ID: 16740036
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
Hultgren TL; DiMaio DJ
J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
[TBL] [Abstract][Full Text] [Related]
37. [Cellular fibrous histiocytoma: a clinicopathologic analysis of 27 cases].
Zhong YP; Wang J
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):153-7. PubMed ID: 23769432
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical ALK Expression in Granular Cell Atypical Fibroxanthoma: A Diagnostic Pitfall for ALK-Rearranged Non-neural Granular Cell Tumor.
Brown RA; Cloutier JM; Bahrani E; Liman A; Tasso D; Palmer A; Manning MA; Galperin I; Rieger KE; Novoa RA; Lau H; Louie CY
Am J Dermatopathol; 2021 Nov; 43(11):831-834. PubMed ID: 33767072
[TBL] [Abstract][Full Text] [Related]
39. Hemangiopericytoma-like dermatofibroma with mast cells.
Aneiros-Fernandez J; Arias-Santiago S; Espiñeira-Carmona MJ; Caba-Molina M; Fernandez-Pugnaire MA; O'Valle F; del Moral RG; Aneiros-Cachaza J
Am J Dermatopathol; 2011 Aug; 33(6):e74-6. PubMed ID: 21712684
[TBL] [Abstract][Full Text] [Related]
40. Amelanotic malignant melanoma: two collision tumors presenting as basal cell carcinoma and atypical fibroxanthoma.
McGregor DH; Cherian R; Romanas MM; Ulusarac O; Mathur SC; Feldman MM
Ann Clin Lab Sci; 2008; 38(2):157-62. PubMed ID: 18469362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
